Shares of VBI Vaccines, Inc. – (NASDAQ:VBIV) saw unusually-high trading volume on Friday . Approximately 187,326 shares traded hands during trading, an increase of 129% from the previous session’s volume of 81,805 shares.The stock last traded at $4.05 and had previously closed at $3.90.

Separately, Ladenburg Thalmann initiated coverage on shares of VBI Vaccines, Inc. – in a report on Tuesday, July 26th. They set a “buy” rating for the company.

The stock’s market capitalization is $148.87 million. The stock has a 50-day moving average of $3.69 and a 200-day moving average of $3.87.

VBI Vaccines Inc, formerly SciVac Therapeutics Inc, is a biotechnology company. The Company is engaged in developing various technologies that focus on vaccine protection. It has developed an enveloped virus like particle (eVLP) vaccine platform that allows for the design of enveloped VLP vaccines. It is involved in various projects related to human cytomegalovirus (CMV) and other antigens.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.